Phase 1 study of the selective BTK inhibitor zanubrutinib in B-cell malignancies and safety and efficacy evaluation in CLL
Titel:
Phase 1 study of the selective BTK inhibitor zanubrutinib in B-cell malignancies and safety and efficacy evaluation in CLL
Auteur:
Tam, Constantine S. Trotman, Judith Opat, Stephen Burger, Jan A. Cull, Gavin Gottlieb, David Harrup, Rosemary Johnston, Patrick B. Marlton, Paula Munoz, Javier Seymour, John F. Simpson, David Tedeschi, Alessandra Elstrom, Rebecca Yu, Yiling Tang, Zhiyu Han, Lynn Huang, Jane Novotny, William Wang, Lai Roberts, Andrew W.